Study provides a comprehensive cellular map of how diabetes disrupts bone immune interactions

FHS
March 4, 2025
3:56 pm

When we think of type 2 diabetes, images of heart problems or kidney damage often come to mind. But lurking quietly behind these well-known complications is another serious threat—bone disease.

Psyence Biomedical : Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial Form 6K | Psychedelic Invest

NEW YORK, December 17, 2024 — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today highlighted recent progress that has been made with

December 19, 2024

The Endpoints Slack interview: Siddhartha Mukherjee on the doctor-writer worldview, AI, and the future of cancer

Siddhartha Mukherjee is something of a biotech Renaissance man. First and foremost, he sees himself as an oncologist. But that core interest has led him

May 15, 2024

8VC, a tech and life sciences VC firm behind Altos Labs, eyes $1B fund

8VC, a venture capital firm that has spread its bets across multiple industries, including biotech and digital health, is aiming to raise about $1 billion

January 30, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.